2nd Quarter - Report

EMERGENT BIOSOLUTIONS INC. for EMERGENT BIOSOLUTIONS INC

Firm
Client
Income
—
Expenses
$630,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R.2366/S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.

LobbyistCovered position, as disclosed
GRANT BARBOSA —
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Office of Natl Drug Control Policy (NDCP); White House Office; Health & Human Services, Dept of (HHS)

Bills named: S. 1457 (117th), S. 4231 (117th), H.R. 2366 (117th), H.R. 2379 (117th)

Health Issues HCR

State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R.2366/S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.

LobbyistCovered position, as disclosed
GRANT BARBOSA —
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); White House Office

Bills named: H.R. 2366 (117th), S. 4231 (117th), H.R. 2379 (117th), S. 1457 (117th)

Homeland Security HOM

State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R.2366/S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.

LobbyistCovered position, as disclosed
GRANT BARBOSA —
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: S. 4231 (117th), H.R. 2379 (117th), S. 1457 (117th), H.R. 2366 (117th)

Budget/Appropriations BUD

State Opioid Response Grants funding Substance Abuse and Mental Health Block Grant funding CARA 3.0 - Comprehensive Addiction and Recovery Act Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R.2379 The State Opioid Response Grant Authorization Act of 2021 Appropriations funding for Fiscal Year 2022 NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone S.4231 - Preparing for the Next Pandemic Act H.R.2366/S.1457 - Stop Fentanyl Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.

LobbyistCovered position, as disclosed
GRANT BARBOSA —
CHRIS FRECH —
KATHERINE GETTY —
JILL HAMAKER —

Contacted: White House Office; Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2379 (117th), S. 1457 (117th), S. 4231 (117th), H.R. 2366 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.